Docetaxel Injection

Docetaxel Injection
Product Description

Indication:Oncology
Modality:Small molecule

Seacross Pharmaceuticals Ltd

  • GB
  • 2021
    On CPHI since
  • 1
    Certificates
  • 1 - 24
    Employees
Company types
Distributor/Import Export
Pharmaceutical company
Primary activities
Finished Formulation products Distributor/Buyer
Specifications
  • CAS Registry Number
    114977-28-5
  • Model
    20mg/1ml,80mg/4ml,160mg/8ml

Seacross Pharmaceuticals Ltd

  • GB
  • 2021
    On CPHI since
  • 1
    Certificates
  • 1 - 24
    Employees
Company types
Distributor/Import Export
Pharmaceutical company
Primary activities
Finished Formulation products Distributor/Buyer

More Products from Seacross Pharmaceuticals Ltd (2)